Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (FRA:BO1)
Germany flag Germany · Delayed Price · Currency is EUR
6.06
+0.02 (0.36%)
At close: Dec 1, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Oral Small-molecule and Injectable Protein Therapeutics
450.71M
Log In
Log In
Log In
Log In
Upgrade
Oral Small-molecule and Injectable Protein Therapeutics Growth
36.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
385.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
33.85%
Log In
Log In
Log In
Log In
Upgrade
Non-United States
51.70M
Log In
Log In
Log In
Log In
Upgrade
Non-United States Growth
37.39%
Log In
Log In
Log In
Log In
Upgrade
Global
13.05M
Log In
Log In
Log In
Log In
Upgrade
Global Growth
140.72%
Log In
Log In
Log In
Log In
Upgrade